Epigenetic regulation of autophagy in gastrointestinal cancers

Saeid Ghavami1, Mozhdeh Zamani2, Mazaher Ahmadi3

  • 1Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Research Institute of Hematology and Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada; Faculty of Medicine in Zabrze, University of Technology in Katowice, Academia of Silesia, 41-800 Zabrze, Poland.

Insights

Targeting autophagy and epigenetics in gastrointestinal cancers (GICs) offers new therapeutic strategies. Understanding these links can help overcome chemoresistance and improve GIC treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Gastrointestinal cancers (GICs) require novel therapeutic strategies.
  • Autophagy plays a dual role in GIC progression, promoting survival or death.
  • Autophagy can inhibit early-stage GIC but induce chemoresistance in advanced stages.

Purpose of the Study:

  • To review the intricate links between autophagy and epigenetics in GICs.
  • To explore how epigenetic mechanisms regulate autophagy in GICs.
  • To discuss the potential of targeting autophagy via epigenetic drugs to treat GICs and overcome chemoresistance.

Main Methods:

  • Literature review focusing on the interplay of autophagy and epigenetics in GICs.
  • Analysis of epigenetic mechanisms (DNA methylation, histone modification, ncRNAs) influencing autophagy.
  • Examination of how epigenetic alterations affect cancer phenotypes and chemoresistance.

Main Results:

  • Epigenetic regulation influences autophagy, impacting GIC progression and chemoresistance.
  • Epigenetic modifications can alter cancer cell proliferation, invasion, and migration.
  • Epidrugs show potential in modulating autophagy to enhance GIC treatment efficacy.

Conclusions:

  • The interplay between autophagy and epigenetics is crucial in GIC development and chemoresistance.
  • Targeting epigenetic regulation of autophagy presents a promising therapeutic avenue for GICs.
  • Further research into epidrugs modulating autophagy could lead to improved GIC treatment strategies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K